Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-D

Clinical Trial Details

TEMPO

Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator (TEMPO)

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Atrial Fibrillation
Study Type: Interventional
Phase: Phase II
Study Start Date: 01/05/2015
Study Completion Date: 12/30/2016

This study is to evaluate the effect of eleclazine (GS-6615) compared to placebo on the overall occurrence of appropriate implantable cardioverter-defibrillator (ICD) interventions (antitachycardia pacing [ATP] or shock) in adults with ICD or cardiac resynchronization therapy-defibrillator (CRT-D).

NCT Number
NCT02104583
Principal Investigator(s)
Sean Beinart, MD
Sponsor(s)
Gilead Sciences
Participant Eligibility
  • Age: 18 - 80
  • Gender: Male, Female

Location

  • Adventist HealthCare Washington Adventist Hospital
    7600 Carroll Avenue
    Takoma Park, MD 20912
    Main: 301-891-7600

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.